Clinical relevance of innovative immunoassays for serum ustekinumab and anti-ustekinumab antibody levels in Crohn's disease.

Yasuhiro MoritaTakayuki Imai Shigeki BambaKenichiro TakahashiOsamu InatomiTakako MiyazakiKenji WatanabeShiro NakamuraAtsushi YoshidaYutaka EndoNaoki OhmiyaTomoyuki TsujikawaAkira Andoh

Published in: Journal of gastroenterology and hepatology (2020)

We developed new assays for serum ustekinumab trough and AUA levels. These assays might provide new insights into therapeutic drug monitoring-based management of Crohn's disease patients under ustekinumab therapy.

Keyphrases

end stage renal disease
ejection fraction
high throughput
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
stem cells
bone marrow